Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Smith

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
The Lancet. Public Health|February 11, 2019
Cancer elimination thresholds: one size does not fit all - Authors' replyMichaela T Hall, Megan A Smith, Julia M L Brotherton, et al.
Preventive Medicine Reports|December 15, 2020
Getting the timing right: Women's views on the best time to announce changes to cancer screening policy recommendationsRachael H Dodd, Brooke Nickel, Megan A Smith, et al.
International Journal of Cancer|February 26, 2021
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV controlMichaela T Hall, Megan A Smith, Kate T Simms, et al.
BMC Infectious Diseases|August 23, 2015
Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New ZealandYoon-Jung Kang, Hazel Lewis, Megan A Smith, et al.
Plos One|February 15, 2018
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from AustraliaMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
BMJ Global Health|August 31, 2025
The role of non-medical providers in increasing access to cervical screening: a scoping reviewMonjura Nisha, Deborah Bateson, Marion Saville, et al.
Elife|October 13, 2023
A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccinationLouiza S Velentzis, Megan A Smith, James Killen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 23, 2021
Oral HPV Infection among Indigenous Australians; Incidence, Persistence, and Clearance at 12-Month Follow-upSneha Sethi, Xiangqun Ju, Annika Antonsson, et al.
Vaccine|March 23, 2011
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in AustraliaMegan A Smith, Jie-Bin Lew, Robert J Walker, et al.
International Journal of Cancer|August 20, 2016
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countriesKate T Simms, Megan A Smith, Jie-Bin Lew, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
The Lancet. Public Health|February 11, 2019
Cancer elimination thresholds: one size does not fit all - Authors' replyMichaela T Hall, Megan A Smith, Julia M L Brotherton, et al.
Preventive Medicine Reports|December 15, 2020
Getting the timing right: Women's views on the best time to announce changes to cancer screening policy recommendationsRachael H Dodd, Brooke Nickel, Megan A Smith, et al.
International Journal of Cancer|February 26, 2021
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV controlMichaela T Hall, Megan A Smith, Kate T Simms, et al.
BMC Infectious Diseases|August 23, 2015
Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New ZealandYoon-Jung Kang, Hazel Lewis, Megan A Smith, et al.
Plos One|February 15, 2018
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from AustraliaMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
BMJ Global Health|August 31, 2025
The role of non-medical providers in increasing access to cervical screening: a scoping reviewMonjura Nisha, Deborah Bateson, Marion Saville, et al.
Elife|October 13, 2023
A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccinationLouiza S Velentzis, Megan A Smith, James Killen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 23, 2021
Oral HPV Infection among Indigenous Australians; Incidence, Persistence, and Clearance at 12-Month Follow-upSneha Sethi, Xiangqun Ju, Annika Antonsson, et al.
Vaccine|March 23, 2011
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in AustraliaMegan A Smith, Jie-Bin Lew, Robert J Walker, et al.
International Journal of Cancer|August 20, 2016
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countriesKate T Simms, Megan A Smith, Jie-Bin Lew, et al.
Pageof 10